Trial Profile
Drug Use Investigation for ARRANON G (Nelarabine) Injection 250mg
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs Nelarabine (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
- Sponsors GSK; Novartis
- 30 Oct 2017 Status changed from recruiting to completed.
- 24 Apr 2017 Planned End Date changed from 18 Aug 2018 to 18 Oct 2017.
- 24 Apr 2017 Planned primary completion date changed from 18 Aug 2018 to 18 Oct 2017.